Form 4 for IMRX Immuneering Corp
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001104659-21-099723 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-03 | IMRX | Amin Biren | CFO, Treas | P - Purchase | $15.00 | +4,175 | 6,898 | +153% | +$62.6K |
| D | 2021-08-04 | 2021-08-03 | IMRX | Amin Biren | CFO, Treas | C - Cnv Deriv | — | +2,723 | 2,723 | New | — |
| D | 2021-08-04 | 2021-08-03 | IMRX | Amin Biren | CFO, Treas | C - Cnv Deriv | — | -2,723 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-03 | P | A | 4,175 | $15.00 | 6,898 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-08-03 | C | A | 2,723 | — | 2,723 | D | — | — | (F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. |
| 3 | Derivative | Series B Preferred Stock | 2021-08-03 | C | D | 2,723 | — | 0 | D | — · — to — | 2,723 Class A Common Stock | (F1) Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis. |